ZAP70 antibody (AA 280-309) (FITC)
Quick Overview for ZAP70 antibody (AA 280-309) (FITC) (ABIN316507)
Target
See all ZAP70 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 280-309
-
Specificity
- This antibody recognises ZAP-70.
-
Characteristics
- Synonyms: ZAP-70, ZAP 70, SRK, 70 kDa zeta-associated protein, Syk-related tyrosine kinase
-
Immunogen
- Peptide corresponding to amino acid residues 280-309 of human ZAP-70, conjugated toKLH
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Flow cytometry (membrane permeabilisation is required).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.1 mg/mL
-
Buffer
- BPS containing 0.09 % Sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
-
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light.
Shelf life: one year from despatch. -
Expiry Date
- 12 months
-
-
- ZAP70 (zeta-Chain (TCR) Associated Protein Kinase 70kDa (ZAP70))
-
Alternative Name
- ZAP70
-
Background
- ZAP 70 is a 70 kDa tyrosine protein kinase which associates with the T-cell receptor (TCR) zeta chain and undergoes phosphorylation following TCR stimulation. ZAP-70 is primarily expressed in T lymphocytes and natural killer cells, where it plays a key role in T-cell receptor (TCR) signalling. Recent studies suggest that ZAP-70 is also expressed in a population of normal immature B-cells and in B-cells from a sub-set of patients with chronic lymphocytic leukaemia.Synonyms: 70 kDa zeta-associated protein, SRK, Syk-related tyrosine kinase, ZAP 70, ZAP-70
-
Gene ID
- 7535
-
UniProt
- P43403
-
Pathways
- TCR Signaling, Ubiquitin Proteasome Pathway
Target
-